FY26 outlook reflects a one-time charge of approximately $3.65 per share for the acquisition of Cidara.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on MRK:
- Merck reports Q4 adjusted EPS $2.04, consensus $2.01
- Merck sees FY26 adjusted EPS $5.00-$5.15, consensus $5.63
- These Are the Stocks Reporting Earnings Today – February 3, 2026
- Notable companies reporting before tomorrow’s open
- Options Volatility and Implied Earnings Moves This Week, February 02 – February 06, 2026